Galectin Therapeutics Inc (NASDAQ:GALT)

2.56
Delayed Data
As of Jul 06
 -0.03 / -1.16%
Today’s Change
2.50
Today|||52-Week Range
16.55
-26.22%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Czirr James C
Executive Chairman
Sale1/31/201593,168$3.22$300.0K-20.50%
Czirr James C
Executive Chairman
Buy1/31/2015166,667$1.80$300.0K-20.50%
Traber Peter G
President & Chief Executive Officer
Buy6/01/20154,000$2.53$10.1K-4.83%
Traber Peter G
President & Chief Executive Officer
Buy8/14/20142,000$4.48$9.0K-44.47%
Traber Peter G
President & Chief Executive Officer
Buy8/14/20142,000$4.44$8.9K-44.47%
Freeman Kevin D
Director
Buy6/01/20152,083$2.70$5.6K-4.83%
Freeman Kevin D
Director
Buy8/15/20141,000$4.70$4.7K-46.44%
Greenberg Arthur R
Director
Buy8/19/20141,000$4.56$4.6K-44.10%
Callicutt Jack W
Chief Financial Officer
Buy8/14/20141,000$4.55$4.6K-44.47%
Traber Peter G
President & Chief Executive Officer
Buy8/13/20141,000$4.42$4.4K-41.55%
Page of 2

To view my watchlist

Not a member yet?

Sign up now for a free account